Journals / Selçuk Tıp Dergisi / 2000 / Cilt: 16 - Sayı: 4

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, cisplatin) treatment results in high grade bladder tumors

İleri evre mesane tümörlerinde neoadjuvan M-VAC (metotreksat, vinblastin, doksorubisin, sisplatin) tedavisi sonuçlarımız

Pages
267–270
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

M-VAC therapy showed it's beneficial effect by decreasing the stage so providing TUR possibility and other alternative surgical procedurs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:During 1996 and 1999, we applied MVAC in 27 patients whose final stage bladder tumor depends on pathological and radiological bases at urological department. 15.4 % had complete response, 34.6 % had partial clinical response, 34.8 % hadn't any clinical response and 19.7% had progression.
📊
Key Findings & Data:One of the patient died due to a wide spreed tumor metastasis and neutropenic sepsis during the treatment.The most common side-effects were nausea- vomiting, transient renal failure, leucopenia, and trombocytopenia.
💡
Conclusion & Impact:M-VAC therapy showed it's beneficial effect by decreasing the stage so providing TUR possibility and other alternative surgical procedurs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sistoskopi · Neoplazm evrelendirilmesi · Tedavi sonucu

Abstract

During 1996 and 1999, we applied MVAC in 27 patients whose final stage bladder tumor depends on pathological and radiological bases at urological department. 15.4 % had complete response, 34.6 % had partial clinical response, 34.8 % hadn't any clinical response and 19.7% had progression. One of the patient died due to a wide spreed tumor metastasis and neutropenic sepsis during the treatment.The most common side-effects were nausea- vomiting, transient renal failure, leucopenia, and trombocytopenia. M-VAC therapy showed it's beneficial effect by decreasing the stage so providing TUR possibility and other alternative surgical procedurs.

Özet

Klinigimizde 1996-1999 tarihleri arasinda radyolojik ve patolojik olarak degerlendirilerek ileri evre mesane tümörü tanisi konmus 27 hastaya neoadjuvan MVAC kemoterapisi uygulandi. % 15.4 klinik tam yanit, % 34.6 klinik kismi yanit, % 34.8 klinik yanitsizlik ve % 19.7 progresyon gözlendi. Hastalardan bir tanesi tedavi sirasinda yaygin tümör metastazi ve nötropenik sepsise bagli olarak yasamini yitirdi. En sik görülen yan etkiler bulanti-kusma, geçici böbrek yetmezligi, lökopeni ve trombositopeni idi. M-VAC tedavisi kinik yanit oraninin çok yüksek olmamasina karsin düsük yan etki profiliyle ileri evre mesane tümörü olan uygun hastalarda stage düsürmek suretiyle TUR ve diger alternatif cerrahi seçeneklerine imkan saglamaktadir.

🔖

Cite This Article

ACAR, A., KARABACAK, K., KARALEZLİ, G. (2000). Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, cisplatin) treatment results in high grade bladder tumors. Selçuk Tıp Dergisi, Cilt: 16 - Sayı: 4, 267–270. https://ajindex.com/articles/319436

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...